Purpose/Objectives: To evaluate the effectiveness of exercise interventions on overall health-related quality of life (HRQOL) and its domains among adults scheduled to, or actively undergoing, cancer treatment.
in adults from diagnosis through their active cancer treatment period? This review complements the authors' review on the effects of exercise interventions on HRQOL or its domains among people who had completed cancer treatment .
Methods Eligibility Criteria
The authors included randomized, controlled trials (RCTs) and quasi-randomized, controlled clinical trials that assessed and reported on effects of exercise interventions on HRQOL or a HRQOL domain as an outcome among people undergoing treatment or scheduled to initiate treatment. Additional inclusion criteria were that participants were diagnosed with cancer as adults (aged 18 years and older) and that the trials compared exercise with no exercise, another intervention, or usual care (e.g., with no specific exercise program prescribed). The authors excluded trials that included people who were terminally ill, receiving hospice care, or both; and trials in which fewer than one-third of the participants were undergoing treatment for either the primary or recurrent cancer.
The authors used the American College of Sports Medicine (1998, 2005 ) definition for exercise: any physical activity causing an increase in energy expenditure involving a planned or structured movement of the body performed in a systematic manner in terms of frequency, intensity, and duration, and designed to maintain or enhance health-related outcomes. Exercise intensity was based on the American College of Sports Medicine (2005) definition. When a quantitative measure of exercise intensity (e.g., rate of perceived exertion or heart rate) was not available, the authors' classification of the exercise intervention as mild, moderate, or vigorous was used.
Patient-reported outcomes from the included trials were categorized into four follow-up intervals (12 weeks, greater than 12 weeks but less than 6 months, 6 months, and greater than 6 months following the exercise intervention) and included overall HRQOL; HRQOL domains including physical function, psychological function, social and economic role function, spiritual well-being, pain, vitality, general health perceptions, and positive attributes; and disease-and treatment-related symptoms.
Information Sources and Data Collection
The Cochrane review described the search strategy in detail. In brief, the authors conducted a comprehensive search of 11 electronic databases through November 2011, without any date or language limits, to obtain eligible trials for the review. Following an initial screening of titles and abstracts, reviewer pairs independently read full-text copies of trials scored as eligible or possibly eligible to confirm eligibility (see Figure 1 ) and then extracted data from eligible trials using a standardized data collection form. For each included study, the parameters of the Cochrane risk-of-bias tool for RCTs and controlled clinical trials were graded as having high, low, or an unclear risk of bias (Higgins, Altman, & Sterne, 2001 ). offers details on these parameters. Differences between paired reviewers were resolved through consensus or the involvement of a third reviewer. The authors attempted to contact trial authors for missing or additional data.
Data Synthesis and Analysis
The authors combined data from trials in a metaanalysis if the data showed no significant clinical heterogeneity. All trials were pooled for a random-effects meta-analysis to determine the pooled intervention effect estimate (odds ratio [OR] and 95% confidence interval [CI] ). Because authors reported trial results either as change in score from baseline to follow-up or follow-up values, meta-analyses for both types of measures and for each follow-up time period were completed. In addition, a weighted mean difference (WMD) was used when trials measured the HRQOL Other bias 0% 25% 50% 75% 100%
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Note. This graph represents the review authors' judgments about each risk of bias item presented as percentages across all included studies.
Figure 2. Risk of Bias
outcome using the same measure or scale and used a standardized mean difference (SMD) when trials measured the HRQOL outcome using different measures or scales. Differences in this type of analysis are reported in terms of units of standard deviation. Although sometimes difficult to interpret, this analysis allows comparisons across numerous instruments measuring the same concept. In addition, a qualitative rather than quantitative analysis of HRQOL or HRQOL domains was performed when significant clinical or statistical heterogeneity was noted. Prespecified subgroup analyses of treatment effect were based on exercise intensity (mild, moderate, or vigorous) and cancer type (breast cancer versus other cancers). The unit of analysis was the person with cancer randomized to each arm of the trial. See for additional details on the data synthesis and analysis, as well as subgroup analysis strategies.
Results

Trial Characteristics
The authors identified 1,896 unique trials, of which 56 met the eligibility criteria and were included in the qualitative synthesis; 37 of these trials were included in the meta-analyses. The majority of trials (n = 54) were parallel RCTs. One trial (Courneya et al., 2003) randomized clusters of psychotherapy classes and two trials (Dimeo et al., 1999; Mock et al., 1997 ) used a quasi-experimental design. The majority of trials (n = 52) were two-arm trials (exercise and comparison arms); four trials were three-arm trials that included a variation of the exercise arm such as aerobic or resistance (Courneya et al., 2007; Segal et al., 2009) , yoga or stretching (Haddad et al., 2011) , or home-based or supervised exercise (Segal et al., 2001) . See Appendix A for details on trial characteristics.
Participants
Of the 4,826 participants randomized in each trial to the exercise or comparison arms, 2,286 (range = 9-337) were randomized to the exercise and 1,985 (range = 5-134) to the comparison group. Six trials did not report the number of participants randomized to the exercise or comparison arms. Thirty trials investigated participants with breast cancer only. Thirty-six trials were conducted among participants who were currently undergoing treatment, 10 trials were conducted among participants scheduled to undergo treatment, and the remaining 10 trials were conducted among participants during and after cancer treatment, where at least twothirds of the participants were still undergoing active treatment.
Intervention
The included trials prescribed exercise programs such as walking, yoga, resistance or strength training, conditioning exercises, or some combination. Thirty-two trials implemented an aerobic exercise program, and 14 trials implemented a combined aerobic and anaerobic program. Forty-one trials reported a definite length of the exercise intervention, which ranged from 3 (Chang et al., 2008; Cheville et al., 2010) to 26 weeks (Cadmus et al., 2009; Segal et al., 2001) , and an additional 13 trials linked the length of the exercise intervention to the duration of hospitalization or cancer treatment. Thirtythree trials assessed HRQOL or HRQOL domains immediately following the exercise intervention. Methods to measure exercise intensity varied, with the majority of trials (n = 28) using a relatively objective intensity measure (i.e., age-predicted maximum heart rate, maximal oxygen consumption, or Borg scale).
Risk of Bias Within Trials
The risk of bias across all trials was moderate to high. Because it was impossible to conceal assignment to the exercise program, all trials demonstrated a high risk of performance bias, in which systematic differences in outcomes measures are the result of knowing the intervention assigned to a study participant. Several of the trials also were subject to detection, attrition, and selection bias (see Figure 2) .
Effects of the Interventions
Various instruments were used to measure HRQOL or HRQOL domains in the included trials. (For a complete listing of these instruments, please contact the first author of this article.) These were grouped by domain for analyses. The included trials showed differences in HRQOL and HRQOL domains as measured at different time points between baseline and follow-up. Results were reported as change from baseline or simply as follow-up scores. The authors preferentially report pooled results for change scores as these take into account baseline variability. Because trials reported data using different time periods and types of measures, the authors conducted a large number of meta-analyses, leading to the possibility of spurious significant results. To interpret the data, the authors present all results in Table 1 to assess the consistency of effects across various time frames and different types of measures. Consistent results lead the authors to be more confident in a finding of significant results.
Overall Health-Related Quality of Life
Changes in HRQOL scores from baseline to followup demonstrated that overall HRQOL following an exercise intervention was significantly higher compared with a control intervention at 12 weeks, but not at follow-up between 12 weeks and 6 months or at 6 months (see Table 2 ). Similar results were found when the authors looked at HRQOL follow-up scores rather than change in scores from baseline to follow-up.
Similar results were reported in four trials without extractable data (Brown et al., 2006; DiSipio et al., 2009; Gomes et al., 2011; Headley et al., 2004) . However, in some cases, the difference in HRQOL was reported as less of a decrease rather than an increase in HRQOL during treatment.
Given the presence of significant heterogeneity in the meta-analysis at a 12 week follow-up (insufficient data available for longer follow-up periods), the authors assessed whether there was an intervention effect in the prespecified subgroups. Participants with cancers other than breast cancer (SMD = 0.55; 95% CI [0.19, 0.92] ), but not those with breast cancer (SMD = 0.4; 95% CI [-0.11, 0.92]) , showed a positive effect with exercise. A moderate-to-vigorous exercise intervention showed a significant effect on HRQOL at 12 weeks (SMD = 0.51; 95% CI [0.13, 0.89]) in contrast to mild intensity exercise, which showed no difference (SMD = 0.45; 95% CI [-0.3, 1.19] ).
Health-Related Quality of Life Domains
The following HRQOL domains showed consistency across follow-up time periods or types of measures.
Fatigue: A significant effect of exercise on reducing fatigue was observed at 12 weeks, whether measured as difference between baseline and follow-up or as scores at follow-up. Although a significant change in fatigue was not observed at longer follow-up times when looking at the difference between baseline and follow-up scores, the authors did note a significant effect at longer time points when reported as follow-up scores.
Subgroup analyses showed a positive effect from exercise on fatigue in participants with cancers other than breast cancer at 12 weeks (SMD = -0.72; 95% CI [-1.23, -0.2]), but not for breast cancer survivors. Exercise also showed a positive effect when reported as moderate-to-vigorous intensity, but only at the 12-week follow-up (SMD = -0.93; 95% CI [-1.6, -0.26] ). The effect of exercise remained significant when the authors excluded trials with participants who had completed treatment (SMD = -0.78; 95% CI [-1.29, -0.27 
]).
Physical functioning: The effect of exercise on physical functioning was consistent at 12 weeks and at 6 months whether measured as difference between baseline and follow-up or as scores at follow-up. This effect, however, was not present at follow-up between 12 weeks and 6 months. There were no significant effects of the exercise intervention on physical functioning based on subgroups by type of cancer or intensity of exercise (data not shown). Three of four trials in which the current authors were unable to extract data also reported a significant difference between treatment groups in physical functioning (Haddad et al., 2011; Mock et al., 1997; Oh et al., 2008) and one reported no difference (Headley et al., 2004) .
Role function: Pooling results of trials evaluating role function showed a significant effect of exercise on role function compared with control for change from baseline to the 12-week follow-up and differences in follow-up scores at 12 weeks and 6 months but not at other time points. Subgroup analyses (data not shown) revealed a significant effect for trials examining types of cancer other than breast (SMD = 0.58; 95% CI [0.04, 1.12]), and when excluding trials that included participants who had completed treatment (SMD = 0.75; 95% CI [0.14, 1.36]) when looking at change from baseline to 12-week follow-up. No effect of exercise intensity was noted. Role function also was measured in two trials from which the current authors were unable to extract data; those trials reported no change in role function in either the exercise or control group (Headley et al., 2004; Oh et al., 2008) .
Social functioning:
The authors observed a significant effect of exercise compared with a control intervention on social functioning at the 12-week follow-up, whether measured as the pooled result of
Knowledge Translation
Evidence from this review shows that moderate-to-vigorous intensity exercise programs have beneficial effects on health-related quality of life (HRQOL).
Exercise programs also had positive effects on HRQOL domains because they enhanced physical, role, and social functioning and reduced fatigue.
Exercise programs can be incorporated into management plans for people scheduled for or actively undergoing cancer treatment.
trials evaluating change from baseline to follow-up or when comparing follow-up scores. A significant effect was also observed at the six-month follow-up, but only when comparing follow-up scores. Subgroup analyses showed that a positive treatment effect was still present if limited to trial participants with breast cancer or other types of cancer (data not shown). One trial where data were not extracted reported no difference in social functioning between the exercise and control groups (Headley et al., 2004) , whereas a second had reported a significant effect on social functioning with exercise without a corresponding effect in the control group (Oh et al., 2008) .
Other domains: The authors observed a pattern of significant findings for three domains (anxiety, depression, and pain) in which the scores at the 12-week follow-up and at the six-month follow-up in the exercise group were significantly different from those in the control group. In addition, the authors observed isolated instances of significant findings for body image, breast cancer concerns, cognitive function, emotional well-being, general health perspective, prostate cancer concerns, sleep disturbance, and spirituality, but only at a single time point or using a single type of measure.
Discussion
This review provides evidence to suggest an exercise intervention positively impacts overall HRQOL and HRQOL domains of fatigue, physical function, role function, and social function among people newly diagnosed with cancer and about to undergo treatment or actively undergoing treatment. The positive effects were consistent across various time frames and different types of tools or scales used to measure these outcomes. Exercise interventions exhibited significantly greater positive impact on HRQOL among people with cancers other than breast cancer. In addition, moderateto-vigorous intensity exercise interventions resulted in greater improvements in HRQOL.
Several, but not all, results documented through this review concur with other systematic reviews (Craft, Vaniterson, Helenowski, Rademaker, & Courneya, 2012; Cramp & Byron-Daniel, 2012; Cramp & Daniel, 2008; Cramp, James, & Lambert, 2010; Duijts, Faber, Oldenburg, van Beurden, & Aaronson, 2011; Ferrer, Huedo-Medina, Johnson, Ryan, & Pescatello, 2011; Speck, Courneya, Masse, Duval, & Schmitz, 2010 ) that evaluated the effectiveness of exercise interventions on HRQOL or HRQOL domains. Unlike the current article, other systematic reviews examined effects of exercise interventions on HRQOL among both people who were undergoing cancer treatment and those who had completed treatment, with only one review (Speck et al., 2010) presenting findings by treatment status. Similar to other reviewers, the current authors have documented significant positive effects of exercise interventions on global HRQOL and fatigue (Cramp & Byron-Daniel, 2012; Cramp & Daniel, 2008) . Unlike other reviews, the current authors observed patterns (at a particular follow-up period or in change scores) but not consistent positive effects on anxiety (Duijts et al., 2011 ), depression (Craft et al., 2012 Duijts et al., 2011) , breast cancer-specific concerns (Speck et al., 2010) , and body image and stress (Duijts et al., 2011) . In addition, Ferrer et al. (2011) reported positive changes in HRQOL based on exercise type and gender (i.e., among women). Some factors that could explain differences in findings between previous reviews and the current review include differences in treatment status of trial participants, types of exercise programs, and instruments used to assess HRQOL outcomes.
Although there are significant advances in research on the benefits of exercise on HRQOL, several areas need additional study to expand the knowledge base. The field could benefit from parsimoniously defined conceptual frameworks or theoretical models that could better inform design and implementation of exercise interventions and assessment of HRQOL outcomes, effect modifiers, mediators, and confounders. These models and frameworks could help postulate and test strategies to sustain changes in exercise behaviors to ensure maintenance of positive effects on HRQOL and HRQOL domains, optimal follow-up periods from the end of the intervention to document changes in behavior, and exercise program-specific elements (i.e., frequency, duration, dose, intensity, type [aerobic and/or anaerobic]) that enhance HRQOL and its domains. In addition, comparison of findings on HRQOL and HRQOL domains across trials is limited because of the heterogeneous measures used to document outcomes. Efforts such as the Patient-Reported Outcomes Measurement Information System (PROMIS) may help address this issue (Cella et al., 2010; National Cancer Institute, 2014 reviewed eligible trials had a common limitation: failure to provide a context within which the exercise intervention effected the outcome. Using mixed-method designs (Creswell, 2014) will enrich the understanding of the intervention delivery and uptake and provide contextually meaningful insights into the processes of behavior change. In addition, the field will benefit by moving from efficacy trials to pragmatic trials (Glasgow, 2013; Glasgow, Magid, Beck, Ritzwoller, & Estabrooks, 2005; Riley, Glasgow, Etheredge, & Abernethy, 2013; Stange, Breslau, Dietrich, & Glasgow, 2012) and by improving the dissemination and implementation (Brownson, Colditz, & Proctor, 2012; Glasgow et al., 2005; Lobb & Colditz, 2013; Tunis, Stryer, & Clancy, 2003) of evidence into practice and policy.
The positive results reported here need to be interpreted with caution. The trials included in the review had varying levels of risk of bias. In addition, the numerous measures used to assess overall HRQOL and HRQOL domains coupled with the heterogeneity of exercise programs not only in the type of program (aerobic or anaerobic) but in the intensity, frequency, duration, and context (home or facility, individual or group, professionally led or not) make comparisons very challenging. The possibility of biased selection of trials included in the review exists. To minimize this bias, two independent reviewers selected trials for inclusion. There also was the possibility of publication bias. The authors prepared funnel plots to assess publication bias for outcomes such as global HRQOL, fatigue, and physical functioning for baseline to follow-up and for follow-up values. Visual inspection of these plots revealed slight asymmetry indicating some publication bias in this area of research. It also is possible that the review missed some potentially eligible trials in the gray literature. Given the strength of associations and concordance of findings across various time frames and different types of measures, it is unlikely that adding trials from the grey literature would significantly affect the findings. The detailed search across 11 electronic databases, correspondence with authors and experts, search of websites, and review of reference lists of retrieved articles makes the authors confident that they accessed most (if not all) of the available literature that met the search criteria. In addition, the multiple comparisons within this review could well result in spurious significant findings by chance. To assess the robustness of the authors' analytical results, findings were compared across time periods and across metrics (i.e., change from baseline versus follow-up scores). Consistent findings across time and metrics increased the authors' confidence in the results.
Conclusions
Evidence from this review suggests that exercise programs, particularly those of moderate-to-vigorous intensity, have beneficial effects on HRQOL and HRQOL domains and can be integrated into the management plans of people scheduled for or undergoing cancer treatment. In addition, evidence from the review supports the incorporation of exercise programs for the management of HRQOL among people scheduled for or undergoing cancer treatment into clinical guidelines, such as the Oncology Nursing Society's Putting Evidence Into Practice resource.
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